Gosset Ownership
Private
Therapeutic Areas
Stage
Preclinical
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Modalities
Spotlight Therapeutics General Information
No clinical results reported as all programs remain at the pre-clinical stage. The company has demonstrated proof-of-concept for its TAGE platform in preclinical models targeting hemoglobinopathies and cancer.
Contact Information
Primary Industry
Biotech
Corporate Office
Hayward, California
United States
United States
Drug Pipeline
No pipeline data available
Key Partnerships
No major pharmaceutical or biotech partnerships publicly disclosed as of May 2025. Company has indicated openness to future partnerships outside its core pipeline focus.
Spotlight Therapeutics Funding
No funding data available
To view Spotlight Therapeutics's complete valuation and funding history, request access »